Vitamin D Supplement Doses and Serum 25-HydroxyvitaminD in the Range Associated with Cancer Prevention

Vitamin D Supplement Doses and Serum 25-HydroxyvitaminD in the Range Associated with Cancer Prevention.png

Anticancer Research February 2011 vol. 31 no. 2 607-611

CEDRIC F. GARLAND, CHRISTINE B. FRENCH, LEO L. BAGGERLY, and ROBERT P. HEANEY

Abstract

BACKGROUND: Studies indicate that intake of vitamin D in the range from 1,100 to 4,000 IU/d and a serum 25-hydroxyvitamin D concentration [25(OH)D] from 60-80 ng/ml may be needed to reduce cancer risk. Few community-based studies allow estimation of the dose-response relationship between oral intake of vitamin D and corresponding serum 25(OH)D in the range above 1,000 IU/d.

MATERIALS AND METHODS: A descriptive study of serum 25(OH)D concentration and self-reported vitamin D intake in a community-based cohort (n = 3,667, mean age 51.3 ± 13.4 y).

RESULTS: Serum 25(OH)D rose as a function of self-reported vitamin D supplement ingestion in a curvilinear fashion, with no intakes of 10,000 IU/d or lower producing 25(OH)D values above the lower-bound of the zone of potential toxicity (200 ng/ml). Unsupplemented all-source input was estimated at 3,300 IU/d. The supplemental dose ensuring that 97.5% of this population achieved a serum 25(OH)D of at least 40 ng/ml was 9,600 IU/d.

CONCLUSION: Universal intake of up to 40,000 IU vitamin D per day is unlikely to result in vitamin D toxicity.

Source: http://ar.iiarjournals.org/content/31/2/607.long